Skip to main content

Table 1 Clinical advantages and disadvantages of 18 F-FDG PET scanning in PAH

From: Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma

Advantages

ā€¢ Commonly available in many hospitals

Ā 

ā€¢ Easy to manufacture and easy to transport

Ā 

ā€¢ Mechanisms which predict an altered tracer activity in PAH have been relatively well studied

Disadvantages

ā€¢ No consensus exists on appropriate patient preparation prior to imaging (e.g. overnight fasting and glucose loading), leading to inconsistencies in results between centers

Ā 

ā€¢ Lung and right ventricular 18F-FDG uptake does not correlate with disease severity or survival

Ā 

ā€¢ Lung and right ventricular 18F-FDG uptake rapidly normalize upon PAH treatment, questioning the utility of 18F-FDG PET in the follow-up of patients

Ā 

ā€¢ Corrections for lung density have not been performed

Ā 

ā€¢ Increased FDG uptake in the heart could either reflect an increase in

Ā 

ā€¢ After load or a direct, after load-independent, change in energy metabolism. It is not possible to determine the relative contributions of both processes